Temasek-Backed Biotech Firm Innovent Seeks To Raise Up To $500M In HK IPO
October 15, 2018 — 10:36 CST
This Data Is Locked!
This area is available only to Subscribers.
Chinese biotech Innovent Biologics, Inc., backed by Singapore’s Temasek Holdings, is seeking to raise US$400 million to US$500 million in an initial public (IPO) offering... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
